Balchem Corporation is excited to announce the acquisition of Cardinal Associates Inc., operating as “Bergstrom Nutrition,” a leading science-based manufacturer of methylsulfonylmethane (MSM), based in Vancouver, Washington.
Ted Harris, Chairman, CEO and President of Balchem, said, “We are excited to welcome Bergstrom Nutrition to Balchem. As the MSM market leader, Bergstrom Nutrition has excelled in advancing the science and presence of MSM globally. The addition of OptiMSM® to our portfolio provides a synergistic scientific advantage in Balchem’s key strategic therapeutic focus areas such as longevity and performance and is a strong fit with Balchem’s specialty, science-backed mineral products. We look forward to expanding marketplace opportunities together.”
Join Ted Harris, Chairman of the Board, President, and CEO and Martin Bengtsson, CFO on Friday, July 26, 2024, at 11:00 AM Eastern Time (ET) to review 2nd Quarter 2024 financial results.
Ted Harris, Chairman, President and CEO said, "We delivered solid second quarter financials with record earnings from operations and adjusted EBITDA. I am particularly pleased with the excellent performance in our Human Nutrition and Health and Specialty Products segments, both delivering strong sales and earnings growth."
×
You are leaving the Balchem Corporation website and linking to a non-affiliated third-party site.
